Author:
Utomo Rudy Setyo,Wibowo M. Agus,Nurmainah ,Burhansyah Rusli
Reference28 articles.
1. F. Gong, H. P. Gu, Q. T. Xu, W. Y. Kang, Genus Mitragyna: Ethnomedicinal uses and pharmacological studies, Phytopharmacology, 3(2) 263–272 (2012).
2. V. Meireles, T. Rosado, M. Barroso, S. Soares, J. Gonçalves, A. Luís, D. Caramelo, A. Y. Simão, N. Fernández, A. P. Duarte and E. Gallardo, Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples, Medicines, 6(35): 1–21 (2019).
3. From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
4. C. Veltri and O. Grundmann, Current perspectives on the impact of Kratom use, Substance Abuse and Rehabilitation, 10: 23–31 (2019).
5. D. Fluyau and N. Revadigar, Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom, Frontier in Psychiatry, 8(62): 1–8 (2017).